This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vilar, M.
Right arrow Articles by Matagne, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vilar, M.
Right arrow Articles by Matagne, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2001, p. 2215-2223, Vol. 45, No. 8
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.8.2215-2223.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Kinetic Study of Two Novel Enantiomeric Tricyclic beta -Lactams Which Efficiently Inactivate Class C beta -Lactamases

Mateja Vilar,1 Moreno Galleni,4 Tom Solmajer,2,3 Boris Turk,1 Jean-Marie Frère,4 and André Matagne4,*

Laboratoire d'Enzymologie, Centre for Protein Engineering, University of Liège, Institut de Chimie, B6, B-4000 Liege (Sart Tilman), Belgium,4 and Department of Biochemistry and Molecular Biology, Institut Jozef Stefan, 1000 Ljubljana,1 Department of Molecular Modelling and NMR Spectroscopy, National Institute of Chemistry, 1115 Ljubljana,2 and Lek, d. d., Research and Development, 1526 Ljubljana,3 Slovenia

Received 19 July 2000/Returned for modification 26 January 2001/Accepted 3 May 2000

A detailed kinetic study of the interaction between two ethylidene derivatives of tricyclic carbapenems, Lek 156 and Lek 157, and representative beta -lactamases and D-alanyl-D-alanine peptidases (DD-peptidases) is presented. Both compounds are very efficient inactivators of the Enterobacter cloacae 908R beta -lactamase, which is usually resistant to inhibition. Preliminary experiments indicate that various extended-spectrum class C beta -lactamases (ACT-1, CMY-1, and MIR-1) are also inactivated. With the E. cloacae 908R enzyme, complete inactivation occurs with a second-order rate constant, k2/K', of 2 × 104 to 4 × 104 M-1 s-1, and reactivation is very slow, with a half-life of >1 h. Accordingly, Lek 157 significantly decreases the MIC of ampicillin for E. cloacae P99, a constitutive class C beta -lactamase overproducer. With the other serine beta -lactamases tested, the covalent adducts exhibit a wide range of stabilities, with half-lives ranging from long (>4 h with the TEM-1 class A enzyme), to medium (10 to 20 min with the OXA-10 class D enzyme), to short (0.2 to 0.4 s with the NmcA class A beta -lactamase). By contrast, both carbapenems behave as good substrates of the Bacillus cereus metallo-beta -lactamase (class B). The Streptomyces sp. strain R61 and K15 extracellular DD-peptidases exhibit low levels of sensitivity to both compounds.


* Corresponding author. Mailing address: Laboratoire d'Enzymologie, Centre for Protein Engineering, University of Liège, Institut de Chimie, B6, B-4000 Liege (Sart Tilman) Belgium. Phone: 32 4 3663419. Fax: 32 4 3663364. E-mail: amatagne{at}ulg.ac.be.


Antimicrobial Agents and Chemotherapy, August 2001, p. 2215-2223, Vol. 45, No. 8
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.8.2215-2223.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Paukner, S., Hesse, L., Prezelj, A., Solmajer, T., Urleb, U. (2009). In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum {beta}-Lactamase Inhibitor. Antimicrob. Agents Chemother. 53: 505-511 [Abstract] [Full Text]